SAGEbio is pioneering a unique discovery-to-manufacturing technology platform, giving access to key biopharmaceuticals.
Extending the SAGEbio full suite discovery-to-manufacturing technology platform by integrating knowledge gained from the current clinical phase candidate development.
Our proprietary discovery platform allows rapid identification of effective high-precision biomolecules. AI integration elicits optimized pharmaceutical parameters. A portfolio of GMP production and background in biopharmaceutical development facilitates partnering for clinical phases.